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Abstract 
Suicidal behavior in schizoaffective disorder is a serious problem and suicide risk during 
lifetime ranges between 5%-10%. Neurobiology of suicidal behavior has not been studied 
sufficiently, and a high number of studies are oriented toward lipid investigation. The aim of 
our study was to investigate whether there were differences in the level of lipids (cholesterol, 
HDL-cholesterol, LDL-cholesterol, triglycerides) in hospitalized suicidal (n=20) and non-
suicidal (n=20) patients with schizoaffective disorder. The study also included male healthy 
control subjects (n=20). Hamilton Depression Rating Scale (HDRS-17), and Positive and 
Negative Syndrome Scale (PANSS) were used to confirm the level of psychopathology in 
patients with schizoaffective disorder. Severity of suicidality was measured by Scale for 
Suicide Ideation (SSI) (Beck et al., 1979) at time of admission. Results of the study indicated 
significantly lower concentrations of cholesterol (p<0.001), LDL-cholesterol (p<0.01) and 
HDL-cholesterol (p<0.01). There were no differences in the number of previous 
hospitalisation and previous suicide attempts between suicidal and non-suicidal patients 
(p>0.05). Duration of the illness was significantly (p<0.05) shorter in suicidal patients. 
Suicidal patients also had a significantly higher score on HDRS-17 (p<0.001) and PANSS 
(p<0.01) compared to non-suicidal patients. 
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 1. Introduction 
Changes in serum concentration of lipids, particularly of cholesterol, are among the most 
studied biological factors in the field of suicidality. In the early 1990s, analyses of mortality 
rates in prevention-related clinical trials showed a correlation between low cholesterol and 
non-illness-related mortality (Muldoon et al., 1990; Lindberg et al., 1992; Neaton et al., 
1992). Further analyses in extensive studies demonstrated the occurrence of suicide as a 
secondary complication, and investigations showed association between low cholesterol and 
recurrent suicide attempts (Zureik et al., 1996; Partonen et al., 1999). Case-control studies 
indicated lower cholesterol levels in patients admitted after suicide attempt as compared to 
admitted non-suicidal patients (Garland et al., 2000; Kim et al., 2002; Diaz-Sastre et al., 
2007). Correlation of low cholesterol level with suicidality has also been confirmed in other 
psychiatric disorders, such as anorexia nervosa (Favaro et al., 2004) and panic disorder (Ozer 
et al., 2004). Our previous studies confirmed the role of cholesterol in suicidal behavior of 
patients diagnosed with different form of psychotic disorders (Marčinko et al., 2004, 2005, 
2007). 
Some studies demonstrated that association of low cholesterol with suicide attempts was more 
pronounced among violent suicide attempters or those with a history of such attempts 
(Alvarez et al., 2000; Vevera et al., 2003; Kim and Myint, 2004; Marčinko et al., 2005). One 
study corroborated causative correlation between low cholesterol and violence in general 
(Golomb, 1998). There have, however, been some case control studies that failed to show an 
association between cholesterol level and suicide attempts (Almeida-Montes  et al., 2000; 
Deisenhammer et al., 2004). Also, some previous epidemiological and clinical studies have 
presented conflicting results on possible associations between low cholesterol levels and 
heightened rates of death from suicide (Tanskanen et al., 2000; Muldoon et al., 2001).  
 Genetic factors have also been investigated as part of the etiology of suicidal behavior 
(Turecki, 2001). Regarding neurobiological research of suicidal behavior in psychotic 
disorders, most studies deal with schizophrenia which actually motivated us to conduct this 
investigation with schizoaffective disorder. The aim of this study was to investigate if there 
were differences in lipid concentrations (cholesterol, HDL cholesterol, LDL-cholesterol, 
triglycerides) between suicidal and non-suicidal patients with schizoaffective disorder on 
hospital treatment, and a healthy, control group.    
 
 
 
2. Methods 
2.1. Sample 
Subjects were male patients (N=40) treated at the Department of Psychiatry, University 
Hospital Zagreb, during the period of 18 months. Within patients, 20 patients were 
consecutively admitted suicidal men with schizoaffective disorder, and 20 patients were 
consecutively admitted men with schizoaffective disorder, without suicidal behavior. The 
diagnosis of schizoaffective disorder was made according to diagnostic criteria of the 
International Statistical Classification of Diseases and Related Health Problems, 10th 
Revision (ICD-10) after performing structured diagnostic psychiatric interview (WHO, 1996). 
All of the patients have depressed type of schizoaffective disorder. Hamilton Depression 
Rating Scale, HDRS-17 (Hamilton, 1960) was applied to assess depressive symptoms. 
Positive and negative syndrome scale, PANSS (Kay et al., 1987) was used to estimate 
psychotic symptoms. The trained psychiatrists performed clinical evaluation. Patients were 
classified as suicidal at the hospital admission if a suicidal ideation, or a suicide attempt, or 
both, was present. Suicidality was assessed positive if item 3 of the HDRS-17 scale was 
scored positively. Severity of suicidality was measured by Scale for Suicide Ideation (SSI) 
(Beck et al., 1979) at the time of admission for all of the participants.  
All participants were free of all medications in the previous 3 months. Healthy male subjects 
(N=20) with no history of psychiatric illness and somatic disorders or diseases were randomly 
selected as a control group. They were recruited from the general population and were closely 
matched for age. All subjects gave written informed consent to participate in the study. This 
study was approved by the Clinical Hospital Center Medical Ethics Committee. 
Only patients whose biochemical analyses from the time of admission were available were 
included in the study. Venous blood samples were collected within 24 hours of admission. 
None of the patients or control subjects included in the study had used any cholesterol-
lowering drugs before the sampling. The exclusion criteria were: hypertension, 
hypothyroidism, diabetes mellitus, disorders of the lipoprotein metabolism, diagnosis of 
substance abuse, including alcoholism, eating disorders and organic brain syndrome. 
 
 
 
2.2. Assessment 
Venipuncture was performed for all subjects between 8 and 9 a.m. after 12 h overnight fast. 
Immediately after collecting blood samples, serum concentrations of cholesterol, HDL-
cholesterol and triglycerides were determined using enzyme method and commercial kits 
(Olympus Diagnostic, GmbH, Hamburg, Germany) on Olympus AU 600 automated analyzer. 
Inter-assay laboratory coefficients of variation were 3.2% for cholesterol, 2.5% for 
triglycerides, and 3.0% for HDL-cholesterol. Reference intervals for the measured parameters 
were as follows: cholesterol < 5.0 mmol/L, LDL < 3.0 mmol/L, HDL > 1.0 mmol/L, and 
triglycerides < 1.7 mmol/L. Height and weight of each patient were recorded while they were 
standing barefoot in light clothes on the medical scale that measures height and weight. Body 
mass index (BMI) was calculated in the way that body weight in kilograms was divided with 
squared height value in meters.  
 
2.3. Data analysis 
The results were expressed as mean values and standard deviations. Kruskal Wallis one way 
analysis of variance was applied for statistical processing of the obtained data during 
comparison of continuous variables across the three subject groups (suicidal patients, non-
suicidal patients and healthy controls). Student t-test was used to compare two groups of 
patients after normal data distribution in some variables had been demonstrated by 
Kolmogorov-Smirnov test. Nonparametric Spearman correlation coefficient test was applied 
in searching relations between variables. In all tests, the criterion of significance was p<0.05. 
Statistical processing of results was done by using commercial statistical package SPSS 11 
(SPSS for Windows 11.0, SPSS, Chicago, IL, USA).  
 
3. Results 
Results of the study are presented in table 1. There were no statistically significant differences 
for BMI and age values between subject groups (p>0.05). Analysis showed that total 
cholesterol values in suicidal patients were statistically significantly lower than in non-
suicidal patients and the control group (p=0.000). Triglyceride levels in suicidal patients were 
not statistically significantly different compared to non-suicidal patients and the control group 
(p=0.255). HDL-cholesterol concentrations in suicidal patients were statistically significantly 
lower than in non-suicidal patients and the control group (p=0.007), also the values of LDL-
cholesterol (p=0.001). In suicidal patients, PANSS values were statistically significantly 
higher than in non-suicidal patients (p=0.004), and the HDRS-17 score was also statistically 
significantly higher in suicidal patients than in non-suicidal ones (p=0.000).  We have no 
found correlation between suicidality (measured by SSI) and symptom severity (measured by 
PANSS, p=0.127  and HDRS, p=0.992). We searched further for a possible correlation 
between biological variables and the score in SSI and did not find any significant correlation 
except for cholesterol. Serum cholesterol and SSI score gave a significant negative correlation 
(Spearman R=-0.867, p=0.005). Also,  we have no found correlation between HDRS score 
and lipid fractions (p>0.05). We have noted in the table, the number /the frequency/ of 
previous suicide attempt and done correlations between the frequencies of suicide and lipid 
profiles. There were no significant correlations for any lipid marker (p>0.05). There were no 
differences in the number of previous hospitalization and previous suicide attempts between 
suicidal and non-suicidal patients (p>0.05). Duration of the illness was significantly (p=0.027) 
shorter in suicidal patients.  
 
 
 
 
4. Discussion 
4.1. Principal findings 
Results of the study showed differences between suicidal and non-suicidal patients with 
schizoaffective disorder both on biological and clinical levels. Suicidal patients had 
statistically significantly lower levels of cholesterol and LDL, while triglyceride and HDL 
values were lower but without a statistically significant difference in relation to non-suicidal 
patients with schizoaffective disorder. Also, suicidality negatively correlated to the level of 
cholesterol which emphasize the possible role of this biological marker in the complex  
process of suicidality.  Decreased cholesterol concentrations in suicidal patients were 
consistent with previous study results (Kim et al., 2002; Kunugi et al, 1997; Marčinko et al., 
2004, 2005, 2007; Modai et al, 1994). Provided that these results are confirmed on a larger 
number of samples, they could be of assistance in recognizing suicidal behavior in routine 
clinical practice. Several different mechanisms have been stated in the literature to account for 
the correlation between low cholesterol level and suicidality. Although biological mechanisms 
of association between low cholesterol and suicidality have not been completely elucidated, 
reduced serum cholesterol level may be accompanied by changes in viscosity and function of 
serotonin receptors and transporters, as well as by decreased serotonin precursors (Engelberg, 
1992). According to a frequently cited study by Engelberg (1992), low cholesterol level may 
be related to decreased lipid microviscosity in neural membranes and may reduce serotonin 
receptor exposure on the membrane surface, which leads to reduced function of serotonin 
receptors. The consequence of inhibited serotonin neurotransmission is lower inhibition of 
impulsive and aggressive behavior, which may trigger suicidal behavior. In line with two 
earlier investigations of depression symptoms and suicidality in psychotic patients (Walsh  et 
al., 2001; Aguilar et al., 2003), our study also confirmed that suicidal patients had more 
pronounced depressive symptoms compared to non-suicidal patients, which was evident in 
higher HDRS-17 score. Suicidal patients may have less appetite, which in turn results in 
lower intakes of certain nutrients such as lipids and, hence, further intensifies vulnerability to 
depressive and suicidal patterns of behavior but we were not found correlation between lipid 
profiles and depressive symptoms and could not confirmed the hypothesis. The lack of 
correlation between HDRS score and cholesterol could be explained by many confounders 
(e.g., poor physical health, dietary habits, social and economical conditions) important in the 
context of suicidality.  
Suicidal patients also had a significantly higher score regarding the scale of psychotic 
symptoms (PANSS), which reflect enhanced severity of schizoaffective disorder. Also, we 
have no found correlation between suicidality and symptom severity, measured by PANSS 
and HDRS which could be explained by the fact that underlying vulnerability to suicidal 
behavior may consist of interrelated different psychological and biological characteristics. 
One of important characteristic should be duration of the illness and we have found 
significantly shorter duration of the illness in suicidal patients. The risk of suicidal behavior in 
psychosis is stressed in the earlier course of the illness (Brown, 1997) what is important in the 
prevention activities.  
As far as we know, our results are the first to show the relationship between reduced 
cholesterol and suicidality in schizoaffective disorder. Since a majority of individuals with 
schizoaffective disorder never attempt suicide, suicidal behavior is viewed as an outcome of 
the possible interaction between biological diathesis and transient mood and/or psychotic 
states or life event triggers. Such a model emphasizes the role of a biological predisposition 
(in the form of lower cholesterol functioning) to lack of behavioral control, that make patients 
more vulnerable to acting on suicidal ideation.  
 
 
4.2. Unanswered questions and future research 
Limitations of this study were a relatively small patient sample and the lack of information on 
patients' nutritive habits, which we plan to perform in one of our further investigations that 
will include a larger number of schizoaffective patients. In the present study there are no data 
available regarding several other factors that may contribute to the alterations in serum 
cholesterol in suicidal patients, such as genetic factors and cigarette smoking. 
 
5. Conclusions 
Our results show that lipids have an important role in distinguishing suicidal from non-
suicidal patients which, if confirmed on a higher number of patients and in more studies, may 
be of considerable clinical significance.  A better understanding of the neurobiology of 
suicide can facilitate the detection of the population of patients who have a high risk to 
attempt suicide, and to develop better treatment interventions for these patients. 
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Table 1. Differences in demographic, biological and clinical parameters between suicidal 
(N=20) and non-suicidal (N=20) patients with schizoaffective disorder and the control group 
(N=20) (mean ±SD). 
 
 
 
 
 
 Suicidal 
(N=20) 
Non-
suicidal  
(N=20) 
Controls 
(N=20) 
Between-group 
comparisons, 
significance level 
(p) 
BMI  25.12±2.06 26.07±1.91 25.61±1.98 0.721 
Age  28.90±8.76 37.35±12.21 29.85±7.57 0.056 
Cholesterol (mmol/L) 4.43±0.67  6.05±1.20 6.00±1.18 0.000 
Triglycerides 
(mmol/L) 
1.68±0.91 2.49±1.95 2.32±1.88 0.255 
HDL-cholesterol 
(mmol/L) 
1.04±0.30 1.29±0.29 1.37±0.49 0.007 
LDL-cholesterol 
(mmol/L) 
2.71±0.48 3.65±1.10 3.64±1.09 0.001 
     
Previous suicide 
attempts 
   0.114 
     Positive 6  2   
     Negative 14 18   
Duration of the illness 
(year) 
6.60±7.04 12.65±9.43  0.027 
Previous 
hospitalization 
(number) 
2.20±1.85 2.25±2  0.935 
PANSS 
(score) 
90.75±15.19 80.75±14.56  0.004 
HDRS-17 (score) 29.45±9.89 16.15±10.15  0.000 
